المؤلفون: Kwon S, Yoo KH, Sym SJ, Khang D

المصدر: International Journal of Nanomedicine, Vol Volume 14, Pp 5925-5942 (2019)

مصطلحات موضوعية: glioblastoma multiforme, tumor inhibition, mesenchymal stem cell, nanocarrier, nerve regeneration, anti-inflammation, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://www.dovepress.com/mesenchymal-stem-cell-therapy-assisted-by-nanotechnology-a-possible-co-peer-reviewed-article-IJN; https://doaj.org/toc/1178-2013

URL الوصول: https://doaj.org/article/f4e3bedf982248fc888c8784baa36faf

المؤلفون: Hong J, Jung M, Kim YJ, Sym SJ, Kyung SY, Park J, Lee SP, Park JW, Cho EK, Jeong SH, Shin DB, Lee JH

المصدر: Cancer Chemotherapy & Pharmacology; Jan2012, Vol. 69 Issue 1, p215-220, 6p

المؤلفون: Sym SJ, Lee DH, Kang HJ, Nam SH, Kim HY, Kim SJ, Eom HS, Kim WS, Suh C

المصدر: Cancer Chemotherapy & Pharmacology; Jun2009, Vol. 64 Issue 1, p27-33, 7p

المؤلفون: Catenacci DV, Kang YK, Uronis HE, Lee KW, Ng MC, Enzinger PC, Park SH, Gold PJ, Lacy J, Hochster HS, Oh SC, Kim YH, Marrone KA, Kelly RJ, Juergens RA, Kim JG, Alcindor T, Sym SJ, Song EK, Chee CE, Chao Y, Kim S, Oh DY, Yen J, Odegaard JI, Lagow E, Li D, Sun J, Kaminker P, Moore PA, Rosales MK, Park H

المصدر: Oncology (Williston Park, N.Y.) [Oncology (Williston Park)] 2023 Apr 25; Vol. 37 (4), pp. 176-183.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: MultiMedia Healthcare Country of Publication: United States NLM ID: 8712059 Publication Model: Print Cited Medium: Internet ISSN: 0890-9091 (Print) Linking ISSN: 08909091 NLM ISO Abbreviation: Oncology (Williston Park) Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma*/drug therapy , Adenocarcinoma*/genetics , Circulating Tumor DNA*/genetics , Stomach Neoplasms*/drug therapy , Stomach Neoplasms*/genetics, Humans ; Biomarkers, Tumor/genetics ; Receptor, ErbB-2/genetics ; Retrospective Studies ; Trastuzumab/therapeutic use

المؤلفون: Kim ST; Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea., Kim SY; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.; Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea., Lee J; Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea., Yun SH; Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea., Kim HC; Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea., Lee WY; Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea., Kim TW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Hong YS; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Lim SB; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Baek JY; Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea., Oh JH; Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea., Ahn JB; Yonsei University College of Medicine, Seoul, Korea., Shin SJ; Yonsei University College of Medicine, Seoul, Korea., Han SW; Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea., Kim SG; Good Gangan Hospital Cancer Center, Pusan, South Korea., Kang SY; Ajou University School of Medicine, Suwon, South Korea., Sym SJ; Gachon University Gil Hospital, Incheon, Korea., Zang DY; Hallym University Medical Center, Hallym University, Anyang, Korea, South Korea., Kim YH; Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea., Choi IS; Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea., Kang JH; Gyeongsang National University, Jinju, Korea., Kim MJ; Statistics and Data Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, South Korea., Park YS; Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Nov 20; Vol. 40 (33), pp. 3868-3877. Date of Electronic Publication: 2022 Jun 30.

نوع المنشور: Clinical Trial, Phase III; Equivalence Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Colonic Neoplasms*/drug therapy , Colonic Neoplasms*/pathology , Organoplatinum Compounds*/therapeutic use , Oxaliplatin*/therapeutic use, Humans ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Capecitabine/therapeutic use ; Chemotherapy, Adjuvant ; Disease-Free Survival ; Fluorouracil/therapeutic use ; Leucovorin/therapeutic use ; Neoplasm Staging

المؤلفون: Lee SH; Department of Radiation Oncology, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea., Ha SY; Department of Pathology, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea., Sym SJ; Division of Medical Oncology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.

المصدر: Urology case reports [Urol Case Rep] 2022 Jun 05; Vol. 44, pp. 102124. Date of Electronic Publication: 2022 Jun 05 (Print Publication: 2022).

نوع المنشور: Case Reports

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101626357 Publication Model: eCollection Cited Medium: Print ISSN: 2214-4420 (Print) Linking ISSN: 22144420 NLM ISO Abbreviation: Urol Case Rep Subsets: PubMed not MEDLINE

المؤلفون: Park JH; Division of Medical Oncology, Departments of Internal Medicine., Yeo JH; Division of Medical Oncology, Departments of Internal Medicine., Kim YS; Division of Medical Oncology, Departments of Internal Medicine., Park I; Division of Medical Oncology, Departments of Internal Medicine., Ahn HK; Division of Medical Oncology, Departments of Internal Medicine., Cho EK; Division of Medical Oncology, Departments of Internal Medicine., Shin DB; Division of Medical Oncology, Departments of Internal Medicine., Yang JY; Surgery., Kim HS; Radiology, Gachon University Gil Medical Center, Incheon, Republic of Korea., Lee WK; Surgery., Sym SJ; Division of Medical Oncology, Departments of Internal Medicine.

المصدر: American journal of clinical oncology [Am J Clin Oncol] 2022 Feb 01; Vol. 45 (2), pp. 61-65.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8207754 Publication Model: Print Cited Medium: Internet ISSN: 1537-453X (Electronic) Linking ISSN: 02773732 NLM ISO Abbreviation: Am J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*therapeutic use , Biosimilar Pharmaceuticals/*therapeutic use , Stomach Neoplasms/*drug therapy , Trastuzumab/*therapeutic use, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents, Immunological/adverse effects ; Biosimilar Pharmaceuticals/adverse effects ; Female ; Humans ; Male ; Middle Aged ; Progression-Free Survival ; Receptor, ErbB-2/metabolism ; Retrospective Studies ; Stomach Neoplasms/mortality ; Stomach Neoplasms/pathology ; Trastuzumab/adverse effects ; Treatment Outcome

المؤلفون: Kang YK; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Chen LT; National Institute of Cancer Research, National Health Research Institutes, and National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan; Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan., Ryu MH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Oh DY; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea; Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Korea., Oh SC; Division of Hematology and Oncology, Department of Internal Medicine, College of Medicine, Korea University, Seoul, South Korea., Chung HC; Division of Medical Oncology, Yonsei Cancer Center, Song-Dang Institute for Cancer Research, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea., Lee KW; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea., Omori T; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Shitara K; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Sakuramoto S; Department of Gastroenterological Surgery, Saitama Medical University International Medical Center, Hidaka, Japan., Chung IJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University College of Medicine, Hwasun, South Korea., Yamaguchi K; Department of Gastroenterological Chemotherapy, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., Kato K; Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Sym SJ; Department of Internal Medicine, Division of Medical Oncology, Gachon University Gil Medical Center, Incheon, South Korea., Kadowaki S; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Tsuji K; Department of Medical Oncology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan., Chen JS; Division of Hematology and Oncology, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan., Bai LY; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, and China Medical University, Taichung, Taiwan., Oh SY; Department of Hemato-Oncology, Dong-a University Hospital, Busan, South Korea., Choda Y; Department of Surgery, Hiroshima Citizens Hospital, Hiroshima, Japan., Yasui H; Department of Medical Oncology, Kobe City Medical Center General Hospital, Hyogo, Japan., Takeuchi K; Department of Oncology Clinical Development Planning, Ono Pharmaceutical, Osaka, Japan., Hirashima Y; Department of Oncology Clinical Development Planning, Ono Pharmaceutical, Osaka, Japan., Hagihara S; Department of Statistical Analysis, Ono Pharmaceutical, Osaka, Japan., Boku N; Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: nboku@ncc.go.jp.

المصدر: The Lancet. Oncology [Lancet Oncol] 2022 Feb; Vol. 23 (2), pp. 234-247. Date of Electronic Publication: 2022 Jan 11.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Esophagogastric Junction*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Esophageal Neoplasms/*drug therapy , Neoplasm Recurrence, Local/*drug therapy , Nivolumab/*therapeutic use , Stomach Neoplasms/*drug therapy, Adult ; Aged ; Aged, 80 and over ; Double-Blind Method ; Esophageal Neoplasms/mortality ; Female ; Humans ; Male ; Receptor, ErbB-2/analysis ; Stomach Neoplasms/mortality

المؤلفون: Jeon Y; Division of Colon and Rectal Surgery, Department of Surgery, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea., Sym SJ; Division of Medical Oncology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea., Yoo BK; College of Pharmacy, Gachon University, Incheon, Republic of Korea., Baek JH; Division of Colon and Rectal Surgery, Department of Surgery, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.

المصدر: Integrative cancer therapies [Integr Cancer Ther] 2022 Jan-Dec; Vol. 21, pp. 15347354221105498.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 101128834 Publication Model: Print Cited Medium: Internet ISSN: 1552-695X (Electronic) Linking ISSN: 15347354 NLM ISO Abbreviation: Integr Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Colonic Neoplasms*/drug therapy , Colorectal Neoplasms* , Curcumin*/therapeutic use , Ginsenosides*/therapeutic use , Rectal Neoplasms*, Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols ; Bevacizumab/adverse effects ; Camptothecin/adverse effects ; Disease-Free Survival ; Female ; Fluorouracil/adverse effects ; Humans ; Lipids/therapeutic use ; Male ; Middle Aged ; Prospective Studies

المؤلفون: Jeon Y; Division of Colon and Rectal Surgery, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea., Han KW; Division of Colon and Rectal Surgery, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea., Lee SH; Department of Radiation Oncology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea., Sym SJ; Division of Hematology and Oncology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea., Choi SJ; Department of Radiology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea., Ha SY; Department of Pathology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea., Baek JH; Division of Colon and Rectal Surgery, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.

المصدر: Korean journal of clinical oncology [Korean J Clin Oncol] 2021 Dec; Vol. 17 (2), pp. 111-116. Date of Electronic Publication: 2021 Dec 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Korean Society of Clinical Oncology Country of Publication: Korea (South) NLM ID: 9918521386106676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2288-4084 (Electronic) Linking ISSN: 22884084 NLM ISO Abbreviation: Korean J Clin Oncol Subsets: PubMed not MEDLINE